Antonios Papanicolau-Sengos, M.D.
Dr. Papanicolau-Sengos is a molecular pathologist. He is interested in targeted oncotherapeutics, the molecular classification of neoplasms, and machine learning applications in molecular pathology
1) neoplasm molecular genomics, 2) epigenetic oncology
I am interested in new analytical technologies in the context of molecular pathology. An example is the application of machine learning techniques on large-scale DNA methylation studies. The combination of these technologies has already proved excellent in helping neuropathologists classify central nervous system (CNS) neoplasms. Another interest of mine is the molecular characterization of rare familial neoplasms which are not currently well-represented in medical literature.
Selected Recent Publications
- Prostate. 79(5): 498-505, 2019. [ Journal Article ]
- J Immunother Cancer. 7(1): 18, 30678715. [ Journal Article ]
- J Immunother Cancer. 7(1): 27, 2019. [ Journal Article ]
Dr. Papanicolau-Sengos received his medical degree from Georgetown School of Medicine and has completed a pathology residency (AP/CP) at the University of California San Diego, a general surgical pathology fellowship at the University of Washington, and a molecular pathology fellowship at ARUP laboratories. Previously, Dr. Papanicolau-Sengos has held positions at the molecular pathology laboratory of Roswell Park Comprehensive Cancer Center and its spin-off company OmniSeq Inc.